"The US Food and Drug Administration (FDA) has approved naldemedine (Symproic) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic noncancer pain, Shionogi Inc and Purdue Pharma LP have announced."...
(sufentanil citrate) Injection
SUFENTA® (sufentanil citrate) is a potent opioid analgesic chemically designated as N-[4-(methyoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide:2-hydroxy-1,2,3-propanetricarboxylate (1:1) with a molecular weight of 578.68. The structural formula of SUFENTA (sufentanil citrate injection) is:
SUFENTA (sufentanil citrate injection) is a sterile, preservative free, aqueous solution containing sufentanil citrate equivalent to 50 µg per mL of sufentanil base for intravenous and epidural injection. The solution has a pH range of 3.5-6.0.
Last reviewed on RxList: 1/9/2017
This monograph has been modified to include the generic and brand name in many instances.
Additional Sufenta Information
- Sufenta Drug Interactions Center: sufentanil citrate iv
- Sufenta Side Effects Center
- Sufenta FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.